1. Home
  2. MHD vs PHAR Comparison

MHD vs PHAR Comparison

Compare MHD & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackrock MuniHoldings Fund Inc.

MHD

Blackrock MuniHoldings Fund Inc.

HOLD

Current Price

$10.16

Market Cap

585.0M

Sector

Finance

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$10.10

Market Cap

793.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MHD
PHAR
Founded
N/A
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
585.0M
793.4M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
MHD
PHAR
Price
$10.16
$10.10
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $38.33
AVG Volume (30 Days)
★ 715.4K
34.1K
Earning Date
01-01-0001
05-07-2026
Dividend Yield
★ 4.16%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$10.04
Revenue Next Year
N/A
$2.51
P/E Ratio
★ N/A
$3,041.22
Revenue Growth
N/A
N/A
52 Week Low
$10.14
$9.62
52 Week High
$12.08
$21.34

Technical Indicators

Market Signals
Indicator
MHD
PHAR
Relative Strength Index (RSI) 18.38 38.04
Support Level N/A $9.62
Resistance Level $11.93 $11.60
Average True Range (ATR) 0.17 0.47
MACD -0.06 -0.03
Stochastic Oscillator 2.04 9.45

Price Performance

Historical Comparison
MHD
PHAR

About MHD Blackrock MuniHoldings Fund Inc.

Blackrock Muniholdings Fund Inc is a diversified, closed-end management investment company. Its investment objective is to provide shareholders with current income exempt from U.S. federal income taxes. The fund mainly invests its managed assets in municipal bonds rated investment grade or, if unrated, are deemed to be of comparable quality by the investment adviser at the time of investment. Its investment portfolio is mainly comprised of long-term municipal bonds with a maturity of more than ten years at the time of investment. The fund can also invest directly in such securities or synthetically through the use of derivatives.

About PHAR Pharming Group N.V.

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

Share on Social Networks: